Patients sue GLP-1 drugmakers over sudden vision loss risk
WSJ reports patients have filed lawsuits against GLP-1 drugmakers alleging risk of sudden vision loss, citing symptoms including blurred vision and reduced peripheral sight.
Michelle Fennell said she was at her desk when her right eye began to feel heavy, then turned blurry and her peripheral vision faded. She said it felt like looking through a fishbowl, with straight-ahead vision intact but sight to the right and downward reduced. Two weeks later, a doctor diagnosed Fen…